Page 164 - MALAYSIA HEALTH SECTOR RESPONSE TO COVID-19 PANDEMIC: PERSPECTIVES FROM THE FIELD

which vaccines to buy. The COVAX facility is a global plan co-led by Gavi,
the Coalition for Epidemic Preparedness Innovations (CEPI), and WHO,
which vaccines to buy. The COVAX facility is a global plan co-led by Gavi,
whose aim is to accelerate the development and manufacture of COVID-19
the Coalition for Epidemic Preparedness Innovations (CEPI), and WHO,
vaccines and to guarantee fair and equitable access for every country in the
whose aim is to accelerate the development and manufacture of COVID-19
14
world .
vaccines and to guarantee fair and equitable access for every country in the
14
world .
The Malaysian government signed another agreement with AstraZeneca to
procure 6.4 million doses of its vaccine to vaccinate another 3.2 million
The Malaysian government signed another agreement with AstraZeneca to
people 12, 15-17 . Besides, at the time of writing, the Malaysian government is
procure 6.4 million doses of its vaccine to vaccinate another 3.2 million
also in the process of negotiating with three other vaccine developers to
people
. Besides, at the time of writing, the Malaysian government is
12, 15-17
purchase 14 million COVID-19 vaccine doses from the China-based Sinovac
also in the process of negotiating with three other vaccine developers to
Biotech Ltd to cover 7 million Malaysians; 3.5 million doses of the single-
purchase 14 million COVID-19 vaccine doses from the China-based Sinovac
dose regimen by another Chinese company, CanSino Biologics Inc, for 3.5
Biotech Ltd to cover 7 million Malaysians; 3.5 million doses of the single-
million Malaysians; and 6.4 million doses of the two-dose Sputnik V vaccine
dose regimen by another Chinese company, CanSino Biologics Inc, for 3.5
regimen by Russia’s state-run Gamaleya National Centre for 3.2 million
million Malaysians; and 6.4 million doses of the two-dose Sputnik V vaccine
Malaysians 12, 15-17 . The procurement of these vaccines had required a total
regimen by Russia’s state-run Gamaleya National Centre for 3.2 million
of RM 2.05 billion to vaccinate 26.5 million or 82.8% of Malaysia’s 32 million
Malaysians
12, 15-17
. The procurement of these vaccines had required a total
population 12, 15-17 .
of RM 2.05 billion to vaccinate 26.5 million or 82.8% of Malaysia’s 32 million
population 12, 15-17 .

Figure 8.2: Procurement of vaccines for 82.8% of the Malaysian population,
as of 22nd December 2020
Figure 8.2: Procurement of vaccines for 82.8% of the Malaysian population,
18
(Source: Facebook Kementerian Sains, Teknologi dan Inovasi, MOSTI )
as of 22nd December 2020
18
(Source: Facebook Kementerian Sains, Teknologi dan Inovasi, MOSTI
Figure 8.2: Procurement of vaccines for 82.8% of the Malaysian population, as )
of 22nd December 2020
(Source: Facebook Kementerian Sains, Teknologi dan Inovasi, MOSTI )
18
161
128 EVIDENCE-BASED RESPONSES TO THE THIRD COVID-19 WAVE IN MALAYSIA
161